10-K: Ethema Health Corporation Reports Net Income of $1 Million in 2023 Despite Operating Loss

Ethema Health Corporation reported a net income of $1 million for 2023, a significant increase from the previous year, despite an operating loss, driven by a gain on property disposal and tax adjustments.

Summary

• Ethema Health Corporation reported a net income of $1,006,415 for the year ended December 31, 2023, a substantial increase from $295,188 in 2022.
• The company experienced an operating loss of $541,920 in 2023, compared to an operating profit of $489,117 in 2022.
• Revenue increased by 10.9% to $5,344,976 in 2023, with patient treatment revenue rising by 17.0% to $5,159,680.
• Rental income decreased by 50.4% to $185,296 due to the disposal of a real property owning subsidiary.
• Operating expenses increased by 35.9% to $5,886,896, driven by higher general and administrative, rent, management, professional fees, and salaries.
• A significant gain of $2,484,172 was realized from the disposal of a property, which positively impacted the net income.
• The company incurred a loss on debt extinguishment of $277,175 and an extension fee on property purchase of $140,000.
• Taxation increased to $391,962 in 2023, compared to a tax benefit of $112,220 in 2022, due to the completion of tax returns for operating subsidiaries.
• Cash used in operating activities was $0.5 million in 2023, a decrease of $2.1 million compared to cash generated of $1.6 million in 2022.
• The company has a working capital deficiency of $7.9 million and total liabilities exceeding assets by $6.2 million as of December 31, 2023.
• Management has assessed the company's liquidity risk as high and states that there is substantial doubt about the company's ability to continue as a going concern.

Sentiment

Score: 5

Explanation: The document presents a mixed picture. While net income improved significantly due to a one-time gain, the underlying operating performance is weak, with an operating loss and high expenses. The company's liquidity risk and going concern issues are major concerns, balancing out the positive net income.

Positives

• The company achieved a significant increase in net income, reaching $1,006,415 in 2023.
• Patient treatment revenue grew by 17.0%, indicating strong performance in core operations.
• The gain on property disposal significantly boosted the company's financial results.
• The company reversed prior period taxation charges and deferred tax balances.

Negatives

• The company experienced an operating loss of $541,920 in 2023.
• Rental income decreased by 50.4% due to the disposal of a real property owning subsidiary.
• Operating expenses increased by 35.9%, impacting profitability.
• The company incurred a loss on debt extinguishment of $277,175.
• The company paid an extension fee on property purchase of $140,000.
• The company has a working capital deficiency of $7.9 million and total liabilities exceeding assets by $6.2 million.

Risks

• The company has a high liquidity risk and may not be able to meet its financial obligations.
• There is substantial doubt about the company's ability to continue as a going concern.
• The company is dependent on raising additional capital through equity or debt financing.
• The company's internal controls over financial reporting are not effective due to material weaknesses.
• The company faces competition from other treatment facilities in the United States.
• The company's stock is considered a penny stock, which may reduce trading activity.

Future Outlook

The company estimates needing approximately $4.8 million in funding over the next twelve months to repay obligations if they are not converted to equity and will need funding for working capital as it seeks opportunities for addiction treatment in the US markets. There is no assurance that the Company will be successful with future financing ventures.

Management Comments

• Management believes that current available resources will not be sufficient to fund the company's planned expenditures over the next 12 months.
• Management has assessed the company's liquidity risk as high.
• Management states that there is substantial doubt about the company's ability to continue as a going concern.

Industry Context

The addiction treatment industry in the USA is competitive, with numerous facilities vying for patients covered by insured healthcare services. Ethema competes with these clinics, relying on relationships with healthcare professionals and in-network agreements with health care providers to source clients.

Comparison to Industry Standards

• The document does not provide specific industry benchmarks for comparison.
• However, the company's reliance on in-network relationships with healthcare providers is a common practice in the addiction treatment industry.
• The company's financial performance, particularly the significant increase in net income due to a one-off property sale, is not necessarily indicative of typical industry performance.
• The company's high liquidity risk and going concern issues are concerning and may be worse than industry standards for established companies.

Related Party Transactions

• The company engaged in several related party transactions, including the disposal of subsidiaries and the exchange of shares for a property owning subsidiary.
• The company has significant payables to related parties, including the CEO, his spouse, and Leon Developments Ltd.

Stakeholder Impact

• Shareholders face potential dilution if the company raises capital through equity issuance.
• Employees may be impacted by the company's financial instability.
• Customers may be affected by the company's ability to continue operations.
• Creditors face the risk of non-payment due to the company's high liquidity risk.

Next Steps

• The company will need to raise additional capital through equity or debt financing.
• The company will continue to seek opportunities for addiction treatment in the US markets.
• The company will work to remediate material weaknesses in internal controls over financial reporting.

Key Dates

Keywords

addiction treatment, healthcare services, financial results, revenue, operating expenses, net income, liquidity risk, going concern, property disposal, debt extinguishment, internal controls, penny stock